Why do we focus on rare diseases?
An estimated 7,000 rare diseases in the world today affect more than 350 million people. Yet only around 5 per cent of these have a cure. This is a hugely under-served area with great unmet medical needs. We specialise in rare diseases because this is where we can make the greatest difference to people’s lives.
At Sobi, we’re dedicated to transforming the lives of people with rare diseases.
We are a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.
Our therapies are concentrated within the areas of Haematology, Immunology and Specialty Care.
We contribute to societies by improving access to treatment of rare diseases.
Every day, we work actively to find better ways to understand and meet patient needs.
Find out more about our business and financial performance.
Here we present our most recent press releases, news articles, and images.